vs
Side-by-side financial comparison of Neptune Insurance Holdings Inc. (NP) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $37.8M, roughly 1.5× Neptune Insurance Holdings Inc.). Neptune Insurance Holdings Inc. runs the higher net margin — 0.1% vs -246.8%, a 246.9% gap on every dollar of revenue. On growth, Neptune Insurance Holdings Inc. posted the faster year-over-year revenue change (28.8% vs 7.6%).
Neptune Insurance Holdings Inc. is a specialty insurance holding company that offers a broad portfolio of property and casualty insurance products, with a core focus on residential and commercial flood insurance for customers across the United States. It serves both individual consumers and small to mid-sized business clients, using advanced data analytics to support accurate policy pricing and robust risk management.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
NP vs VNDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.8M | $57.2M |
| Net Profit | $50.0K | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | — | -70.5% |
| Net Margin | 0.1% | -246.8% |
| Revenue YoY | 28.8% | 7.6% |
| Net Profit YoY | 0.0% | -2774.3% |
| EPS (diluted) | $0.05 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $37.8M | — | ||
| Q4 25 | — | $57.2M | ||
| Q3 25 | $44.4M | $56.3M | ||
| Q2 25 | — | $52.6M | ||
| Q1 25 | — | $50.0M | ||
| Q4 24 | — | $53.2M | ||
| Q3 24 | $33.8M | $47.7M | ||
| Q2 24 | — | $50.5M |
| Q1 26 | $50.0K | — | ||
| Q4 25 | — | $-141.2M | ||
| Q3 25 | $11.5M | $-22.6M | ||
| Q2 25 | — | $-27.2M | ||
| Q1 25 | — | $-29.5M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $12.1M | $-5.3M | ||
| Q2 24 | — | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | -70.5% | ||
| Q3 25 | 46.7% | -55.6% | ||
| Q2 25 | — | -73.2% | ||
| Q1 25 | — | -82.0% | ||
| Q4 24 | — | -19.3% | ||
| Q3 24 | 58.6% | -23.1% | ||
| Q2 24 | — | -20.1% |
| Q1 26 | 0.1% | — | ||
| Q4 25 | — | -246.8% | ||
| Q3 25 | 25.9% | -40.1% | ||
| Q2 25 | — | -51.7% | ||
| Q1 25 | — | -58.9% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | 35.8% | -11.2% | ||
| Q2 24 | — | -9.0% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $-2.40 | ||
| Q3 25 | $0.06 | $-0.38 | ||
| Q2 25 | — | $-0.46 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $0.06 | $-0.09 | ||
| Q2 24 | — | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $327.2M |
| Total Assets | — | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $84.9M | ||
| Q3 25 | $12.2M | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $247.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $327.2M | ||
| Q3 25 | $-509.5M | $466.0M | ||
| Q2 25 | — | $486.3M | ||
| Q1 25 | — | $511.4M | ||
| Q4 24 | — | $538.5M | ||
| Q3 24 | $-374.3M | $541.2M | ||
| Q2 24 | — | $542.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $488.9M | ||
| Q3 25 | $89.6M | $601.1M | ||
| Q2 25 | — | $624.7M | ||
| Q1 25 | — | $631.9M | ||
| Q4 24 | — | $656.2M | ||
| Q3 24 | — | $645.1M | ||
| Q2 24 | — | $651.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-29.5M |
| FCF MarginFCF / Revenue | — | -51.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-29.4M | ||
| Q3 25 | $38.9M | $-31.6M | ||
| Q2 25 | — | $-15.3M | ||
| Q1 25 | — | $-33.1M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-6.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-29.5M | ||
| Q3 25 | — | $-31.8M | ||
| Q2 25 | — | $-15.6M | ||
| Q1 25 | — | $-33.6M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | — | $-14.7M | ||
| Q2 24 | — | $-7.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | -51.6% | ||
| Q3 25 | — | -56.5% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -67.1% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -30.9% | ||
| Q2 24 | — | -13.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NP
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
